Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Helen Rees

Showing results (171-180 of 195) with videos related to

Pageof 20
Sort By:
Journal of Fungi (Basel, Switzerland)|April 3, 2021
The Destructive Tree Pathogen <i>Phytophthora ramorum</i> Originates from the Laurosilva Forests of East AsiaThomas Jung, Marília Horta Jung, Joan F Webber, et al.
AIDS Research and Human Retroviruses|May 13, 2020
Effects of Depot Medroxyprogesterone Acetate, Copper Intrauterine Devices, and Levonorgestrel Implants on Early HIV Disease ProgressionCharles S Morrison, G Justus Hofmeyr, Katherine K Thomas, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|July 24, 2020
Age-Specific Risk Scores Do Not Improve HIV-1 Prediction Among Women in South AfricaKathryn Peebles, Thesla Palanee-Phillips, Jennifer E Balkus, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|October 28, 2021
HIV Incidence Among Pregnant and Nonpregnant Women in the FACTS-001 Trial: Implications for HIV Prevention, Especially PrEP UseHelen Rees, Matthew Francis Chersich, Richard J Munthali, et al.
Preventive Medicine Reports|August 14, 2023
State-of-the-Science of human papillomavirus vaccination in women with human immunodeficiency Virus: Summary of a scientific workshopAnne E Schuind, Helen Rees, John Schiller, et al.
Lancet (London, England)|September 17, 2021
Considerations in boosting COVID-19 vaccine immune responsesPhilip R Krause, Thomas R Fleming, Richard Peto, et al.
The Lancet. Infectious Diseases|December 4, 2018
Tenofovir 1% vaginal gel for prevention of HIV-1 infection in women in South Africa (FACTS-001): a phase 3, randomised, double-blind, placebo-controlled trialSinead Delany-Moretlwe, Carl Lombard, Deborah Baron, et al.
The New England Journal of Medicine|December 2, 2020
Placebo-Controlled Trials of Covid-19 Vaccines - Why We Still Need Them, Philip R Krause, Thomas R Fleming, et al.
Vaccine|February 15, 2022
Building the concept for WHO Evidence Considerations for Vaccine Policy (ECVP): Tuberculosis vaccines intended for adults and adolescents as a test caseSonali Kochhar, Draurio Barreira, Pauline Beattie, et al.
The New England Journal of Medicine|June 23, 2021
SARS-CoV-2 Variants and VaccinesPhilip R Krause, Thomas R Fleming, Ira M Longini, et al.
Pageof 20

Showing results (171-180 of 195) with videos related to

Sort By:
Pageof 20
Journal of Fungi (Basel, Switzerland)|April 3, 2021
The Destructive Tree Pathogen <i>Phytophthora ramorum</i> Originates from the Laurosilva Forests of East AsiaThomas Jung, Marília Horta Jung, Joan F Webber, et al.
AIDS Research and Human Retroviruses|May 13, 2020
Effects of Depot Medroxyprogesterone Acetate, Copper Intrauterine Devices, and Levonorgestrel Implants on Early HIV Disease ProgressionCharles S Morrison, G Justus Hofmeyr, Katherine K Thomas, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|July 24, 2020
Age-Specific Risk Scores Do Not Improve HIV-1 Prediction Among Women in South AfricaKathryn Peebles, Thesla Palanee-Phillips, Jennifer E Balkus, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|October 28, 2021
HIV Incidence Among Pregnant and Nonpregnant Women in the FACTS-001 Trial: Implications for HIV Prevention, Especially PrEP UseHelen Rees, Matthew Francis Chersich, Richard J Munthali, et al.
Preventive Medicine Reports|August 14, 2023
State-of-the-Science of human papillomavirus vaccination in women with human immunodeficiency Virus: Summary of a scientific workshopAnne E Schuind, Helen Rees, John Schiller, et al.
Lancet (London, England)|September 17, 2021
Considerations in boosting COVID-19 vaccine immune responsesPhilip R Krause, Thomas R Fleming, Richard Peto, et al.
The Lancet. Infectious Diseases|December 4, 2018
Tenofovir 1% vaginal gel for prevention of HIV-1 infection in women in South Africa (FACTS-001): a phase 3, randomised, double-blind, placebo-controlled trialSinead Delany-Moretlwe, Carl Lombard, Deborah Baron, et al.
The New England Journal of Medicine|December 2, 2020
Placebo-Controlled Trials of Covid-19 Vaccines - Why We Still Need Them, Philip R Krause, Thomas R Fleming, et al.
Vaccine|February 15, 2022
Building the concept for WHO Evidence Considerations for Vaccine Policy (ECVP): Tuberculosis vaccines intended for adults and adolescents as a test caseSonali Kochhar, Draurio Barreira, Pauline Beattie, et al.
The New England Journal of Medicine|June 23, 2021
SARS-CoV-2 Variants and VaccinesPhilip R Krause, Thomas R Fleming, Ira M Longini, et al.
Pageof 20